DANVERS, Mass.--(BUSINESS WIRE)--The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for Impella RP to include patients suffering from COVID-19 related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback